An Independent Reading Room, Not a Storefront

Why this site exists

Search results for these peptides are crowded with pages promising instructions, sources, and fast outcomes. Much harder to find is a page that simply says what the published research found — and is equally clear about what it did not find.

Avant Peptides was built to be that second kind of page. Research claims trace back to a specific study, trial, or regulatory document, listed in full on the references page and cited by number in the text. Where the evidence is strong, we say so. Where it consists mainly of rodent work plus a tiny human safety pilot, we say that too ^[17][18].

The organizing idea: the translational gap

Every compound here started as a laboratory hypothesis. What separates them is how far each has traveled since — the scale of human testing, whether it earned regulatory approval, and the exact condition covered by that approval. We call that distance the translational gap. It is the single lens this site uses across every page: not "is this peptide good or bad," but "how much evidence exists, and for which claim?"

That framing matters because the gap can disappear behind the phrase "studies show." Such a phrase might describe a cardiovascular outcomes trial with 17,604 participants ^[3] or a safety pilot with two participants ^[17]. Both statements can look equally confident on a page while resting on very different foundations. Avant Peptides names the study type, population, and scale whenever those details matter.

How we handle community reports

Alongside the published clinical literature, some of these compounds — particularly BPC-157 and PT-141 — have active online communities reporting personal experiences. Those reports show what people notice and discuss, and we include them where relevant, but label them clearly as anecdotal, not clinical evidence. We never attach a specific dose to a community report. A recurring self-reported pattern can help frame a question; it is still not the same thing as a controlled trial, and this site does not conflate the two.

What this site is not

Avant Peptides is not a clinic, pharmacy, or vendor. It sells nothing, prescribes nothing, and recommends no dose to any reader. Nothing here is medical advice or a substitute for care from a qualified clinician. Where a compound is an approved prescription medicine, the site says so and marks the scope of that approval; where a compound remains an unapproved research chemical, the site says that plainly as well.

The goal is narrow and specific: to provide an honest account of how far the evidence reaches for each compound before stronger claims are accepted. It is a reading room for comparing evidence, not a service for making personal treatment decisions.